PRECISION BIOSCIENCES INC — Director's Dealing 2021

Oct 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2021-10-15

Reporting Person: Amoroso Michael (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-15	Employee Stock Option (Right to Buy)	$9.79	A	850000	Acquired	2031-10-14	Common Stock (850000)	Direct
2021-10-15	Restricted Stock Units	$	A	24208	Acquired		Common Stock (24208)	Direct

Footnotes

F1: The option vests as to 25% of the underlying shares on October 15, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

F2: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.

F3: The RSUs shall vest on October 15, 2022, subject to the Reporting Person's continued service to the Company through the vesting date.